JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 2, 2008; DOI: 10.1124/jpet.108.137463


0022-3565/08/3261-117-126$20.00
JPET 326:117-126, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.108.137463v1
326/1/117    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, H.
Right arrow Articles by Pang, K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, H.
Right arrow Articles by Pang, K. S.

METABOLISM, TRANSPORT, AND PHARMACOGENOMICS

A Catenary Model to Study Transport and Conjugation of Baicalein, a Bioactive Flavonoid, in the Caco-2 Cell Monolayer: Demonstration of Substrate Inhibition

Huadong Sun, Li Zhang, Edwin Chiu Yuen Chow, Ge Lin, Zhong Zuo, and K. Sandy Pang

Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada (H.S., E.C.Y.C., K.S.P.); and School of Pharmacy (L.Z., Z.Z.) and Department of Pharmacology (G.L.), Faculty of Medicine, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, People's Republic of China

The transport and metabolism of baicalein (Ba) was studied in vitro and in Caco-2 cells. Protein binding of Ba with Caco-2 lysate showed that Ba was bound to two classes of sites: a higher affinity, lower capacity site (KA1 = 27.6 ± 4.7 µM–1, n1 = 10.6 ± 0.6 nmol/mg) and lower affinity, higher capacity site (KA2 = 0.015 ± 0.0013 µM–1, n2 = 413 ± 21 nmol/mg). Incubation studies of Ba with Caco-2 lysate showed substrate inhibition of both glucuronidation and sulfation, with Km values of 0.14 ± 0.034 and 0.015 ± 0.0053 µM, and KI values of 6.75 ± 1.70 and 0.37 ± 0.16 µM, respectively. In the Caco-2 monolayer, Ba (8–47 µM) displayed good apparent permeabilities (Papp) across the membrane; Papp was found to be increased with elevated loading concentration in both the absorptive and secretory directions. However, the efflux ratio was less than unity, negating the involvement of apical efflux transporters. The concentration ratios of Ba sulfate (BS) and glucuronide (BG) decreased with increased loading Ba concentration, suggesting that BS and BG are apically excreted via transporters, likely breast cancer resistance protein and multidrug resistance-associated protein 2, respectively. Data fit to the catenary model, composed of basolateral, cellular, and apical compartments, showed a low cellular unbound fraction (0.0019 ± 0.00018), a high passive diffusion clearance (0.012 ± 0.00029 ml/min/mg), and substrate inhibition, with sulfation being more readily saturated and inhibited than glucuronidation, as evidenced by smaller Km value (0.35 ± 0.078 versus 1.95 ± 0.57 µM) and KI value (0.58 ± 0.20 versus 7.90 ± 1.10 µM); these patterns paralleled those observed in the lysate incubation studies. The results showed that the catenary model aptly predicts substrate inhibition kinetics and offers significant and mechanistic insight into the transport and atypical metabolism of drugs in the Caco-2 monolayer.


Received for publication February 3, 2008
Accepted April 1, 2008.

Address correspondence to. Dr. K. Sandy Pang, Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St., Toronto, ON M5S 3M2, Canada. E-mail: ks.pang{at}utoronto.ca




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
K. Howe, G. G. Gibson, T. Coleman, and N. Plant
In Silico and in Vitro Modeling of Hepatocyte Drug Transport Processes: Importance of ABCC2 Expression Levels in the Disposition of Carboxydichlorofluroscein
Drug Metab. Dispos., February 1, 2009; 37(2): 391 - 399.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.